1. Home
  2. BCTXW
  3. BCTXW News

Latest BriaCell Therapeutics Corp. Warrant (BCTXW) News on November 15, 2024

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
BCTXW

GlobeNewswire

7 days ago

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13
BCTXW

GlobeNewswire

11 days ago

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

BCTXW

MT Newswires

24 days ago

BriaCell Higher as it Reports "Standard-Beating" Survival Data From Phase 2 Study

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
BCTXW

GlobeNewswire

24 days ago

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

BCTXW

MT Newswires

a month ago

BriaCell to Complete Patient Enrollment for Phase 3 Breast Cancer Study by Mid-2025; Shares Rise

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
BCTXW

GlobeNewswire

a month ago

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

BCTXW

MT Newswires

a month ago

BriaCell Therapeutics Closes Offering of 5.13 Million Shares, Warrants

BriaCell Therapeutics Announces Closing of $5 Million Offering
BCTXW

GlobeNewswire

a month ago

BriaCell Therapeutics Announces Closing of $5 Million Offering

BCTXW

MT Newswires

a month ago

BriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering

BCTXW

MT Newswires

a month ago

BriaCell Therapeutics Down 41% as it Announces US$5-Million Share-Unit Offering

BriaCell Therapeutics Announces $5 Million Offering
BCTXW

GlobeNewswire

a month ago

BriaCell Therapeutics Announces $5 Million Offering

BCTXW

MT Newswires

a month ago

BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor
BCTXW

GlobeNewswire

a month ago

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock
BCTXW

Zacks

2 months ago

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

BCTXW

MT Newswires

2 months ago

BriaCell Says FDA Greenlit Expanded Access Policy for Metastatic Breast Cancer Patients

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients
BCTXW

GlobeNewswire

2 months ago

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

BCTXW

MT Newswires

2 months ago

BriaCell Therapeutics Closes $8.5 Million Offering

BriaCell Therapeutics Announces Closing of $8.5 Million Offering
BCTXW

GlobeNewswire

2 months ago

BriaCell Therapeutics Announces Closing of $8.5 Million Offering

BCTXW

MT Newswires

2 months ago

BriaCell Therapeutics Announces US$8.5 Million Share Offering

BCTXW

MT Newswires

2 months ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

BCTXW

MT Newswires

2 months ago

BriaCell Therapeutics Prices $8.5 Million Offering

BriaCell Therapeutics Announces $8.5 Million Offering
BCTXW

GlobeNewswire

2 months ago

BriaCell Therapeutics Announces $8.5 Million Offering

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday
BCTXW

Benzinga

2 months ago

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday

BCTXW

MT Newswires

2 months ago

Update: BriaCell Shares Surge After Reporting Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study

BCTXW

MT Newswires

2 months ago

Sector Update: Health Care Stocks Narrowly Mixed Premarket Wednesday

BCTXW

MT Newswires

2 months ago

BriaCell Reports Longer Overall Survival Rate in Phase 2 Breast Cancer Study

BCTXW

MT Newswires

2 months ago

BriaCell Reports Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study - Shares Soar Premarket

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer
BCTXW

GlobeNewswire

2 months ago

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer

BCTXW

MT Newswires

2 months ago

BriaCell Receives Positive Feedback From FDA Meeting Over Potential Prostate Cancer Drug

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer
BCTXW

GlobeNewswire

2 months ago

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer

BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
BCTXW

GlobeNewswire

2 months ago

BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer
BCTXW

GlobeNewswire

4 months ago

BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer

BriaCell Presents Clinical Efficacy Data at ASCO 2024
BCTXW

GlobeNewswire

5 months ago

BriaCell Presents Clinical Efficacy Data at ASCO 2024

BCTXW

MT Newswires

6 months ago

BriaCell Begins Patient Enrollment in First-in-Human Study of Bria-OTS in Advanced Metastatic Breast Cancer

BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer
BCTXW

GlobeNewswire

6 months ago

BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer

BCTXW

MT Newswires

6 months ago

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study

BCTXW

MT Newswires

6 months ago

BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study
BCTXW

GlobeNewswire

6 months ago

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study

BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
BCTXW

GlobeNewswire

6 months ago

BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024

This BriaCell Therapeutics Insider Increased Their Holding By 55% Last Year
BCTXW

Simply Wall St.

6 months ago

This BriaCell Therapeutics Insider Increased Their Holding By 55% Last Year

BCTXW

MT Newswires

6 months ago

Briacell Therapeutics Insider Bought Shares Worth $2,000,001, According to a Recent SEC Filing

BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
BCTXW

GlobeNewswire

6 months ago

BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

BCTXW

MT Newswires

6 months ago

BriaCell Therapeutics Prices $5 Million Offering; Shares Tumble

BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering
BCTXW

GlobeNewswire

6 months ago

BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering

BCTXW

MT Newswires

7 months ago

BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting

BriaCell Announces Oral and Poster Presentations at ASCO 2024
BCTXW

GlobeNewswire

7 months ago

BriaCell Announces Oral and Poster Presentations at ASCO 2024

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer
BCTXW

GlobeNewswire

7 months ago

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR
BCTXW

GlobeNewswire

7 months ago

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies
BCTXW

GlobeNewswire

8 months ago

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference
BCTXW

GlobeNewswire

8 months ago

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference

BriaCell Provides Update on Alleged Illegal Trading of Public Securities
BCTXW

GlobeNewswire

9 months ago

BriaCell Provides Update on Alleged Illegal Trading of Public Securities

Get Rich Quick With These 3 Penny Stocks to Buy Now
BCTXW

InvestorPlace

9 months ago

Get Rich Quick With These 3 Penny Stocks to Buy Now

BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case
BCTXW

GlobeNewswire

9 months ago

BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing
BCTXW

GlobeNewswire

9 months ago

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
BCTXW

GlobeNewswire

10 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Merchants Bancorp (MBIN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
BCTXW

Zacks

10 months ago

Merchants Bancorp (MBIN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

BCTXW

Reuters

10 months ago

UPDATE 1-Brazil's Lula slams miner Vale over 2019 Brumadinho disaster

BCTXW

GlobeNewswire

10 months ago

Optical Brighteners Market to Hit US$ 2,656.2 Million by 2033 | Updated Insights Report by Persistence Market Research

BCTXW

GlobeNewswire

10 months ago

Irradiation Sterilization Services Market anticipated to grow at CAGR of 9.2% by 2030, According to Persistence Market Research

Q-Gold Comments on Trading Activity at Request of the Canadian Investment Regulatory Organization (“CIRO”)
BCTXW

GlobeNewswire

10 months ago

Q-Gold Comments on Trading Activity at Request of the Canadian Investment Regulatory Organization (“CIRO”)

Manufacturing Activity in Central U.S. Drops Sharply at Start of Year
BCTXW

Barrons.com

10 months ago

Manufacturing Activity in Central U.S. Drops Sharply at Start of Year

BCTXW

GlobeNewswire

10 months ago

Automatic Self-cleaning Cat Litter Box Market to Hit US$ 1,262.7 Million by 2030 | Updated Insights Report by Persistence Market Research

Global Automated Parking System (APS) Market Set to Reach $6.6 Billion by 2030: Surging Demand for Space-Efficient and Technologically Advanced Vehicle Storage Solutions
BCTXW

GlobeNewswire

10 months ago

Global Automated Parking System (APS) Market Set to Reach $6.6 Billion by 2030: Surging Demand for Space-Efficient and Technologically Advanced Vehicle Storage Solutions

Data Storage Corporation Expands Contract with a Global Telecommunications Company
BCTXW

GlobeNewswire

10 months ago

Data Storage Corporation Expands Contract with a Global Telecommunications Company

Silynxcom Receives $400,000 Follow Up Order from a Leading Global Defense Company
BCTXW

GlobeNewswire

10 months ago

Silynxcom Receives $400,000 Follow Up Order from a Leading Global Defense Company

Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR
BCTXW

ACCESSWIRE

10 months ago

Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR

Atlantic Union (AUB) Beats Q4 Earnings and Revenue Estimates
BCTXW

Zacks

10 months ago

Atlantic Union (AUB) Beats Q4 Earnings and Revenue Estimates

Silynxcom Announces Closing of Initial Public Offering
BCTXW

GlobeNewswire

10 months ago

Silynxcom Announces Closing of Initial Public Offering

Akerna Announces Special Meeting Date to Vote on Merger with Gryphon Digital Mining, Inc.; Effectiveness of Registration Statement on Form S-4 in Connection with Merger
BCTXW

GlobeNewswire

10 months ago

Akerna Announces Special Meeting Date to Vote on Merger with Gryphon Digital Mining, Inc.; Effectiveness of Registration Statement on Form S-4 in Connection with Merger

BCTXW

ACCESSWIRE

10 months ago

Nocera Inc. Announces Senior Leadership Change

Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million
BCTXW

Business Wire

10 months ago

Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million

BCTXW

Business Wire

10 months ago

Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer
BCTXW

GlobeNewswire

10 months ago

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

BCTXW

Business Wire

10 months ago

Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement

BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients
BCTXW

GlobeNewswire

a year ago

BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain
BCTXW

ACCESSWIRE

a year ago

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain

BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset
BCTXW

GlobeNewswire

a year ago

BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset

BCTXW

Zacks Small Cap Research

a year ago

BCTX: Down in San Antone

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine
BCTXW

GlobeNewswire

a year ago

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine

Why Fast-paced Mover Cemtrex Inc. (CETX) Is a Great Choice for Value Investors
BCTXW

Zacks

a year ago

Why Fast-paced Mover Cemtrex Inc. (CETX) Is a Great Choice for Value Investors

BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS
BCTXW

GlobeNewswire

a year ago

BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS

BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit
BCTXW

GlobeNewswire

a year ago

BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit

Did Motus Holdings Limited (JSE:MTH) Use Debt To Deliver Its ROE Of 19%?
BCTXW

Simply Wall St.

a year ago

Did Motus Holdings Limited (JSE:MTH) Use Debt To Deliver Its ROE Of 19%?

Sunshine Biopharma Moves Principal Office to New York City
BCTXW

GlobeNewswire

a year ago

Sunshine Biopharma Moves Principal Office to New York City

STRATA Skin Science Announces Strengthening of Leadership Team
BCTXW

GlobeNewswire

a year ago

STRATA Skin Science Announces Strengthening of Leadership Team

Reborn Coffee Announces Grand Opening of Flagship Store in Kuala Lumpur, Malaysia
BCTXW

GlobeNewswire

a year ago

Reborn Coffee Announces Grand Opening of Flagship Store in Kuala Lumpur, Malaysia

BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor
BCTXW

GlobeNewswire

a year ago

BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor

13 Stocks Insiders are Buying Now
BCTXW

Insider Monkey

a year ago

13 Stocks Insiders are Buying Now

Activist group boosts its offer to buy New York-based Carver
BCTXW

American Banker

a year ago

Activist group boosts its offer to buy New York-based Carver

Volcon ePowersports Welcomes Doug Cline as Director of Sales for the United States
BCTXW

GlobeNewswire

a year ago

Volcon ePowersports Welcomes Doug Cline as Director of Sales for the United States

At R102, Is Motus Holdings Limited (JSE:MTH) Worth Looking At Closely?
BCTXW

Simply Wall St.

a year ago

At R102, Is Motus Holdings Limited (JSE:MTH) Worth Looking At Closely?

Electra Provides Notice of Third Quarter 2023 Results Conference Call and Webcast
BCTXW

Business Wire

a year ago

Electra Provides Notice of Third Quarter 2023 Results Conference Call and Webcast

BCTXW

GlobeNewswire

a year ago

UCLOUDLINK GROUP INC. Announces Unaudited Third Quarter 2023 Financial Results

BCTXW

Thomson Reuters StreetEvents

a year ago

Q3 2023 Eagle Point Credit Company Inc Earnings Call

FSI ANNOUNCES THIRD QUARTER, 2023 FINANCIAL RESULTS
BCTXW

GlobeNewswire

a year ago

FSI ANNOUNCES THIRD QUARTER, 2023 FINANCIAL RESULTS

BCTXW

Associated Press Finance

a year ago

SuperCom: Q3 Earnings Snapshot

SuperCom Reports 550% YoY EBITDA Growth and 5-Year-Record Net Profit for the Third Quarter 2023
BCTXW

PR Newswire

a year ago

SuperCom Reports 550% YoY EBITDA Growth and 5-Year-Record Net Profit for the Third Quarter 2023

Electra Postpones Third Quarter 2023 Results Conference Call and Webcast
BCTXW

Business Wire

a year ago

Electra Postpones Third Quarter 2023 Results Conference Call and Webcast

Camber Energy Reports Significantly Higher Revenues Post VKIN Merger
BCTXW

ACCESSWIRE

a year ago

Camber Energy Reports Significantly Higher Revenues Post VKIN Merger

Twin Vee Powercats Co. (NASDAQ:VEEE) Q3 2023 Earnings Call Transcript
BCTXW

Insider Monkey

a year ago

Twin Vee Powercats Co. (NASDAQ:VEEE) Q3 2023 Earnings Call Transcript

Share on Social Networks: